Correlation Between Molecular Partners and Agilent Technologies
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Agilent Technologies, you can compare the effects of market volatilities on Molecular Partners and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Agilent Technologies.
Diversification Opportunities for Molecular Partners and Agilent Technologies
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Agilent is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of Molecular Partners i.e., Molecular Partners and Agilent Technologies go up and down completely randomly.
Pair Corralation between Molecular Partners and Agilent Technologies
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 4.53 times more return on investment than Agilent Technologies. However, Molecular Partners is 4.53 times more volatile than Agilent Technologies. It trades about 0.04 of its potential returns per unit of risk. Agilent Technologies is currently generating about -0.08 per unit of risk. If you would invest 509.00 in Molecular Partners AG on September 30, 2024 and sell it today you would earn a total of 21.00 from holding Molecular Partners AG or generate 4.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Molecular Partners AG vs. Agilent Technologies
Performance |
Timeline |
Molecular Partners |
Agilent Technologies |
Molecular Partners and Agilent Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and Agilent Technologies
The main advantage of trading using opposite Molecular Partners and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Agilent Technologies vs. Twist Bioscience Corp | Agilent Technologies vs. Natera Inc | Agilent Technologies vs. Guardant Health | Agilent Technologies vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |